|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of ProQR Therapeutics (NASDAQ: PRQR) through any online brokerage.
There are no as such competitors for ProQR Therapeutics.
The latest price target for ProQR Therapeutics (NASDAQ: PRQR) was reported by Stifel on May 3, 2021. The analyst firm set a price target for 20.00 expecting PRQR to rise to within 12 months (a possible 163.50% upside). 2 analyst firms have reported ratings in the last year.
The stock price for ProQR Therapeutics (NASDAQ: PRQR) is $7.59 last updated Fri Jun 18 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for ProQR Therapeutics.
There is no upcoming split for ProQR Therapeutics.
ProQR Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.